Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

1. Biden administration announces price negotiations for 15 prescription drugs. 2. Drugs represented 14% of Medicare Part D costs, totaling $41 billion. 3. Successful negotiations could lead to $1.5 billion savings for enrollees in 2026. 4. Pharmaceutical industry fears revenue loss from Medicare price negotiations. 5. Further negotiations planned for more drugs, expanding the program by 2029.